Opportunity for PACS Investors to Lead Securities Fraud Lawsuit against PACS Group, Inc.
Investors who have suffered losses recently may have the opportunity to take the lead in a securities fraud class action lawsuit against PACS Group, Inc. (“PACS Group” or the “Company”) (NYSE: PACS). The Class Period for this lawsuit is April 11, 2024, through November 5, 2024.
If you’re interested in becoming the lead plaintiff in this case, you can share your contact details on www.glancylaw.com/cases/PACS-Group-Inc/. For more information about your rights, you can also reach out to Charles H. Linehan at GPM via phone at 310-201-9150 or Toll-Free at 888-773-9224, or email at shareholders@glancylaw.com. The Lead Plaintiff Deadline for this lawsuit is January 13, 2025.
According to the complaint filed, there are allegations that during the Class Period, the Defendants failed to inform investors of certain key details:
1. The Company was reportedly involved in a “scheme” that involved submitting false Medicare claims, leading to over 100% of PACS’ operating and net income between 2020 and 2023.
2. The Company was also allegedly involved in a “scheme” to bill Medicare for thousands of unnecessary respiratory and sensory integration therapies.
3. Furthermore, there are claims that the Company participated in a scheme to falsify documentation related to licensure and staff.
This information is crucial for investors who may have been affected by the actions of PACS Group, Inc. If you have experienced losses and want to take action, consider reaching out to the appropriate channels mentioned above to learn more about your potential for involvement in the lawsuit.
